Intercept Pharmaceuticals CEO and Key Executive Team

• Paolo Fundarò

  Chairman of the Board
• Luciano Adorini

  Chief Scientific Officer
• Jerome Durso

  Chief Executive Officer at Intercept Pharmaceuticals, Chief Executive Officer
• Bryan Ball

  Chief Quality Officer
• Srinivas Akkaraju

  Director
• Mark Pruzanski

  Director
• Luca Benatti

  Director
• Lisa Defrancesco

  Senior Vice President, Investor Relations & Corporate Affairs
• Gail Cawkwell

  Senior Vice President Medical Affairs, Safety, and Pharmacovigalence
• Daniel Bradbury

  Director
• David Ford

  Chief Human Resources Officer
• Keith Gottesdiener

  Director
• Sandip Kapadia

  Chief Financial Officer and Treasurer
• Nancy Miller-Rich

  Director
• Linda Richardson

  Chief Commercial Officer
• Richard Kim

  President, U.S. Commercial & Strategic Marketing
• Gino Santini

  Board Member
• Jared M. Freedberg

  General Counsel
• Andrew Saik

  Chief Financial Officer
• Glenn Sblendorio

  Director
• Dagmar Rosa-Bjorkeson

  Director
• Rocco Venezia

  Chief Accounting Officer; Acting Chief Financial Officer & Treasurer
• Daniel Welch

  Director

Source: interceptpharma.com